Lack of dendritic cell maturation by the plant toxin ricin
暂无分享,去创建一个
[1] M. Edidin. The state of lipid rafts: from model membranes to cells. , 2003, Annual review of biophysics and biomolecular structure.
[2] J. Mcghee,et al. Cholera toxin activates dendritic cells through dependence on GM1‐ganglioside which is mediated by NF‐κB translocation , 2003, European journal of immunology.
[3] E. Tartour,et al. The B subunit of Shiga toxin coupled to full-size antigenic protein elicits humoral and cell-mediated immune responses associated with a Th1-dominant polarization. , 2003, International immunology.
[4] G. van Meer,et al. Role of Lipids in the Retrograde Pathway of Ricin Intoxication , 2003, Traffic.
[5] Bali Pulendran,et al. Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin , 2003, Nature.
[6] T. Hirst,et al. Selective induction of CD8+CD4- thymocyte apoptosis mediated by the B-subunit of Escherichia coli heat-labile enterotoxin. , 2003, Immunology letters.
[7] L. Pike. Lipid rafts Published, JLR Papers in Press, February 1, 2003. DOI 10.1194/jlr.R200021-JLR200 , 2003, Journal of Lipid Research.
[8] Yue Sun,et al. Pertussis Toxin Enhances Th1 Responses by Stimulation of Dendritic Cells 1 , 2003, The Journal of Immunology.
[9] M. Goldman,et al. Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell activation in whole blood: impaired responses in human newborns , 2002, European journal of immunology.
[10] R. Tuskan,et al. Pertussis toxin and the adenylate cyclase toxin from Bordetella pertussis activate human monocyte‐derived dendritic cells and dominantly inhibit cytokine production through a cAMP‐dependent pathway , 2002, Journal of leukocyte biology.
[11] George K. Lewis,et al. Cholera Toxin and Heat-Labile Enterotoxin Activate Human Monocyte-Derived Dendritic Cells and Dominantly Inhibit Cytokine Production through a Cyclic AMP-Dependent Pathway , 2002, Infection and Immunity.
[12] E. Tartour,et al. 1st Class Ticket to Class I: Protein Toxins as Pathfinders for Antigen Presentation , 2002, Traffic.
[13] A. Firan,et al. A novel recombinant vaccine which protects mice against ricin intoxication. , 2002, Vaccine.
[14] M. Isaka,et al. Effects of Recombinant Cholera Toxin B Subunit on IL‐1β Production by Macrophages In Vitro , 2002, Microbiology and immunology.
[15] G. Fedele,et al. Native and genetically inactivated pertussis toxins induce human dendritic cell maturation and synergize with lipopolysaccharide in promoting T helper type 1 responses. , 2002, The Journal of infectious diseases.
[16] V. Cerundolo,et al. Exogenous Peptides Delivered by Ricin Require Processing by Signal Peptidase for Transporter Associated with Antigen Processing-Independent MHC Class I-Restricted Presentation1 , 2002, The Journal of Immunology.
[17] T. Hirst,et al. Modulation of human monocytes by Escherichia coli heat‐labile enterotoxin B‐subunit; altered cytokine production and its functional consequences , 2002, Immunology.
[18] D. Golenbock,et al. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. , 2002, Journal of cell science.
[19] T. Hirst,et al. Escherichia coli heat-labile enterotoxin B subunit prevents autoimmune arthritis through induction of regulatory CD4+ T cells. , 2002, Arthritis and rheumatism.
[20] K. Triantafilou,et al. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. , 2002, Trends in immunology.
[21] Daniel C. Smith,et al. The low lysine content of ricin A chain reduces the risk of proteolytic degradation after translocation from the endoplasmic reticulum to the cytosol. , 2002, Biochemistry.
[22] Yuetsu Tanaka,et al. Microbial Compounds Selectively Induce Th1 Cell-Promoting or Th2 Cell-Promoting Dendritic Cells In Vitro with Diverse Th Cell-Polarizing Signals1 , 2002, The Journal of Immunology.
[23] C. Watts,et al. Phagocytosis and antigen presentation. , 2001, Seminars in immunology.
[24] Joshua M. Korn,et al. The plasticity of dendritic cell responses to pathogens and their components. , 2001, Science.
[25] M. Lebens,et al. Cholera Toxin B Subunit as a Carrier Molecule Promotes Antigen Presentation and Increases CD40 and CD86 Expression on Antigen-Presenting Cells , 2001, Infection and Immunity.
[26] J. Salamero,et al. Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. , 2001, Molecular biology of the cell.
[27] E. Merritt,et al. A mutant cholera toxin B subunit that binds GM1- ganglioside but lacks immunomodulatory or toxic activity , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[28] E. V. Van Damme,et al. Ribosome‐inactivating proteins from plants: more than RNA N‐glycosidases? , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] A. Mackie,et al. Fluorescence recovery after photobleaching reveals that LPS rapidly transfers from CD14 to hsp70 and hsp90 on the cell membrane. , 2001, Journal of cell science.
[30] J. Pascal,et al. 2.8‐Å crystal structure of a nontoxic type‐II ribosome‐inactivating protein, ebulin l , 2001, Proteins.
[31] Antonio Lanzavecchia,et al. Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming , 2000, European journal of immunology.
[32] J. Davey,et al. Ricin A chain utilises the endoplasmic reticulum‐associated protein degradation pathway to enter the cytosol of yeast , 1999, FEBS letters.
[33] D. Smith,et al. Toxin entry: how bacterial proteins get into mammalian cells , 1999, Cellular microbiology.
[34] W. Lencer,et al. Membrane traffic and the cellular uptake of cholera toxin. , 1999, Biochimica et biophysica acta.
[35] Chang‐you Wu,et al. Cholera Toxin Suppresses Interleukin (IL)-12 Production and IL-12 Receptor β1 and β2 Chain Expression , 1999, The Journal of experimental medicine.
[36] S. Yamasaki,et al. Induction of cytokines in a human colon epithelial cell line by Shiga toxin 1 (Stx1) and Stx2 but not by non‐toxic mutant Stx1 which lacks N‐glycosidase activity , 1999, FEBS letters.
[37] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[38] D. Smith,et al. Expression of mutant dynamin protects cells against diphtheria toxin but not against ricin. , 1998, Experimental cell research.
[39] M. Albert,et al. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs , 1998, Nature.
[40] G. Griffiths,et al. Local and systemic responses against ricin toxin promoted by toxoid or peptide vaccines alone or in liposomal formulations. , 1998, Vaccine.
[41] R. Read,et al. Accumulating evidence suggests that several AB-toxins subvert the endoplasmic reticulum-associated protein degradation pathway to enter target cells. , 1997, Biochemistry.
[42] A. Rapak,et al. Retrograde transport of mutant ricin to the endoplasmic reticulum with subsequent translocation to cytosol. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[43] Francesca Granucci,et al. Maturation Stages of Mouse Dendritic Cells in Growth Factor–dependent Long-Term Cultures , 1997, The Journal of experimental medicine.
[44] J. Pascal,et al. Structure and activity of an active site substitution of ricin A chain. , 1996, Biochemistry.
[45] V. V. van Hinsbergh,et al. Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. , 1996, Blood.
[46] W. Balch,et al. Ricin Cytotoxicity Is Sensitive to Recycling between the Endoplasmic Reticulum and the Golgi Complex (*) , 1995, The Journal of Biological Chemistry.
[47] C Danieli,et al. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products , 1995, The Journal of experimental medicine.
[48] A. Lanzavecchia,et al. CD40 ligand‐independent B cell activation revealed by CD40 ligand‐deficient T cell clones: evidence for distinct activation requirements for antibody formation and B cell proliferation , 1995, European journal of immunology.
[49] P. Rice,et al. Protection against inhalation toxicity of ricin and abrin by immunisation , 1995, Human & experimental toxicology.
[50] D. Derbyshire,et al. X-ray structure of recombinant ricin A-chain at 1.8 A resolution. , 1994, Journal of molecular biology.
[51] J. Samuel,et al. Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages , 1994, Infection and immunity.
[52] F. Sallusto,et al. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.
[53] A. Bolognesi,et al. Ricin induces the production of tumour necrosis factor-alpha and interleukin-1 beta by human peripheral-blood mononuclear cells. , 1993, The Biochemical journal.
[54] F. Arias,et al. Ebulin 1, a nontoxic novel type 2 ribosome-inactivating protein from Sambucus ebulus L. leaves. , 1993, The Journal of biological chemistry.
[55] Kristian Prydz,et al. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum , 1992, Nature.
[56] M. Moser,et al. Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo , 1992, The Journal of experimental medicine.
[57] A. Pihl,et al. Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells. , 1980, Experimental cell research.
[58] Giovanna Lucchini,et al. The Plasticity of Dendritic Cell Responses to Pathogens and Their Components , 2001 .
[59] G. Griffiths,et al. Inhalation Toxicology and Histopathology of Ricin and Abrin Toxins , 1995 .
[60] M. James,et al. Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 A resolution. , 1994, Nature structural biology.
[61] F. Oliveri,et al. Myeloma based expression system for production of large mammalian proteins. , 1991, Trends in biotechnology.
[62] A. Pihl,et al. Toxic lectins and related proteins , 1982 .